Product ID: SQMIG35I2258
Global Topical Pain Relief Market Size, Share, Growth Analysis, By Type(Prescription Pain Relief, Over-the-counter (OTC) Pain Relief), By Therapeutic Class(Non-opioids, Nonsteroidal anti-inflammatory drug (NSAIDS)), By Distribution Channel(Pharmacy & Drug Store, e-Commerce) - Industry Forecast 2024-2031
Report ID:
SQMIG35I2258 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
95 |
Figures:
66
Global Topical Pain Relief Market News
-
In September 2023, NBA Star Giannis Antetokounmpo invested in Flexpower. Thousands of professional athletes in the NBA, NFL, U.S. Women’s Soccer, U.S. Olympics and more purportedly rely on Flexpower topical lotions to get warmed up before games to ease muscle pain, and to speed recovery after tough workouts.
-
In June 2023, Silo Pharma announced a new research and development agreement to create a time-release ketamine implant to treat fibromyalgia and other chronic pain conditions. The development-stage biopharma company has a portfolio of therapies in its pipeline that merge traditional therapeutics with the latest psychedelic research in its pipeline.
-
In May 2023, ASX-listed Wellnex Life entered into a binding agreement to acquire topical pain relief brand Pain Away Australia for A$22 million. The company will undertake an equity raise to fund the deal, which includes $1.15 million of inventory at cost and is payable in cash, subject to satisfaction of certain customary conditions by no later than July 31.
Global Topical Pain Relief Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
